Luo K - Search Results

1

Clinical predictors of pathologically response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: long term outcomes of a phase II study.

Tan Z, Yang H, Wen J, Luo K, Liu Q, Hu Y, Zhang L, Liu M, Yun J, Fu J. Tan Z, et al. Among authors: luo k. J Thorac Dis. 2018 Sep;10(9):5254-5259. doi: 10.21037/jtd.2018.08.88. J Thorac Dis. 2018. PMID: 30416772 Free PMC article.

2

Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.

Wen J, Zheng B, Hu Y, Zhang X, Yang H, Luo KJ, Zhang X, Li YF, Fu JH. Wen J, et al. Oncol Rep. 2009 Jul;22(1):65-71. doi: 10.3892/or_00000407. Oncol Rep. 2009. PMID: 19513506

3

Comparative proteomic analysis of the esophageal squamous carcinoma cell line EC109 and its multi-drug resistant subline EC109/CDDP.

Wen J, Zheng B, Hu Y, Zhang X, Yang H, Li Y, Zhang CY, Luo KJ, Zang X, Li YF, Guan XY, Fu JH. Wen J, et al. Int J Oncol. 2010 Jan;36(1):265-74. Int J Oncol. 2010. PMID: 19956855

4

[Efficacy of surgical resection of left and right transthoracic approaches for middle thoracic esophageal squamous cell carcinoma].

Luo KJ, Fu JH, Hu Y, Rong TH, Lin P, Wang X, Yang H, Zheng B, Li YF. Luo KJ, et al. Ai Zheng. 2009 Dec;28(12):1260-4. doi: 10.5732/cjc.008.10660. Ai Zheng. 2009. PMID: 19958619 Free article. Chinese.

5

Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy.

Hu Y, Zheng B, Rong TH, Fu JH, Zhu ZH, Yang H, Luo KJ, Li YF. Hu Y, et al. Chin J Cancer. 2010 Feb;29(2):178-83. doi: 10.5732/cjc.009.10314. Chin J Cancer. 2010. PMID: 20109347 Free article.

6

[Clinical evaluation of endoscopic ultrasonography and CT in the prediction of the resectability of esophageal carcinoma].

Hu Y, Zheng B, Fu JH, Rong TH, Yang H, Luo KJ, Li YF, Zhu ZH. Hu Y, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2010 Mar;13(3):205-9. Zhonghua Wei Chang Wai Ke Za Zhi. 2010. PMID: 20336540 Chinese.

7

[Significance of subcarinal lymph node selective dissection in thoracic esophageal carcinoma].

Li YF, Hu Y, Lin P, Zheng B, Luo KJ, Yang H, Yang HX, Wang JY, Rong TH, Fu JH. Li YF, et al. Zhonghua Yi Xue Za Zhi. 2010 Oct 12;90(37):2636-9. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21162932 Chinese.

8

CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis.

Luo KJ, Hu Y, Wen J, Fu JH. Luo KJ, et al. J Surg Oncol. 2011 Sep 1;104(3):236-43. doi: 10.1002/jso.21921. Epub 2011 Apr 7. J Surg Oncol. 2011. PMID: 21480261

9

Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.

Luo KJ, Wen J, Xie X, Fu JH, Luo RZ, Wu QL, Hu Y. Luo KJ, et al. Ann Thorac Surg. 2012 May;93(5):1682-8. doi: 10.1016/j.athoracsur.2012.01.102. Epub 2012 Apr 4. Ann Thorac Surg. 2012. PMID: 22480390

10

[Analysis of learning process of video-assisted minimally invasive esophagectomy for thoracic esophageal carcinoma].

Xie X, Fu JH, Wang JY, Zhang X, Luo KJ, Yang F, Amos EB, Li XH. Xie X, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Sep;15(9):918-21. Zhonghua Wei Chang Wai Ke Za Zhi. 2012. PMID: 22990923 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,953 results

Search Page

Filters